Atypical Presentation of Aromatic L-Amino Acid Decarboxylase Deficiency with Developmental Epileptic Encephalopathy

Abstract

Aromatic L-amino acid decarboxylase (AADC) deficiency is an autosomal recessive metabolic disorder resulting from disease-causing pathogenic variants of the dopa decarboxylase (DDC) gene. The neurological features of AADC deficiency include early-onset hypotonia, oculogyric crises, ptosis, dystonia, hypokinesia, impaired development, and autonomic dysfunction. In this article, we reported a patient with genetically confirmed AADC deficiency presenting with developmental epileptic encephalopathy (DEE). Our patient was a boy with severe intractable epileptic spasms and DEE. The patient was evaluated for cognitive and neurologic impairment. Exome sequencing revealed a homozygous mutation (NM_000790.4:c.121C > A; p.Leu41Met) in the DDC gene. This case expands the clinical spectrum of AADC deficiency and strengthens the association between dopa decarboxylase deficiency and epilepsy. Additional studies are warranted to clarify the mechanisms linking dopa decarboxylase dysfunction to DEE.

Keywords

epileptic spasms - developmental epileptic encephalopathy - AADC deficiency - dopa decarboxylase - DDC gene

Publication History

Received: 18 August 2020

Accepted: 22 December 2020

Article published online:
09 February 2021

• References

• 1 Monteleone B, Hyland K. Case report: discovery of 2 gene variants for aromatic L-amino acid decarboxylase deficiency in 2 African American siblings. BMC Neurol 2020; 20 (01) 12
• 2 Himmelreich N, Montioli R, Bertoldi M. et al. Aromatic amino acid decarboxylase deficiency: molecular and metabolic basis and therapeutic outlook. Mol Genet Metab 2019; 127 (01) 12-22
• 3 Ito S, Nakayama T, Ide S. et al. Aromatic L-amino acid decarboxylase deficiency associated with epilepsy mimicking non-epileptic involuntary movements. Dev Med Child Neurol 2008; 50 (11) 876-878
• 4 Anselm IA, Darras BT. Catecholamine toxicity in aromatic L-amino acid decarboxylase deficiency. Pediatr Neurol 2006; 35 (02) 142-144
• 5 Manegold C, Hoffmann GF, Degen I. et al. Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up. J Inherit Metab Dis 2009; 32 (03) 371-380
• 6 Kojima K, Nakajima T, Taga N. et al. Gene therapy improves motor and mental function of aromatic L-amino acid decarboxylase deficiency. Brain 2019; 142 (02) 322-333
• 7 Fusco C, Leuzzi V, Striano P. et al. Aromatic L-amino Acid Decarboxylase (AADC) deficiency: results from an Italian modified Delphi consensus. Ital J Pediatr 2021; 47 (01) 13
• 8 Pearson TS, Gilbert L, Opladen T. et al. AADC deficiency from infancy to adulthood: Symptoms and developmental outcome in an international cohort of 63 patients. J Inherit Metab Dis 2020; 43 (05) 1121-1130
• 9 Lee WT, Lin JH, Weng WC, Peng SSF. Microstructural changes of brain in patients with aromatic L-amino acid decarboxylase deficiency. Hum Brain Mapp 2017; 38 (03) 1532-1540
• 10 Heyne HO, Singh T, Stamberger H. et al. De novo variants in neurodevelopmental disorders with epilepsy. Nat Genet 2018; 50 (07) 1048-1053